Showing results (471-480 of 495) with videos related to

Sort By:
Pageof 50
Hepatology International|August 31, 2025
Management of acute variceal bleeding: updated APASL guidelinesCosmas Rinaldi Adithya Lesmana, Akash Shukla, Ashish Kumar, et al.
Hepatology International|April 8, 2020
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide studyZhen-Hua Chen, Xiu-Ping Zhang, Yu-Gang Lu, et al.
Hepatology International|October 8, 2016
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 updateGamal Shiha, Alaa Ibrahim, Ahmed Helmy, et al.
Hepatology International|February 3, 2021
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter studyLei Liang, Bing Quan, Han Wu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.
International Journal of Surgery (London, England)|May 10, 2023
Postoperative infectious complications following laparoscopic versus open hepatectomy for hepatocellular carcinoma: a multicenter propensity score analysis of 3876 patientsJia-Le Pu, Xiao Xu, Lan-Lan Chen, et al.
Hepatology International|August 24, 2021
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapyGeorge Lau, Ming-Lung Yu, Grace Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
Nature Communications|March 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trialLi-Ting Liu, Xue-Song Sun, Ting-Ting Quan, et al.
JAMA Oncology|June 18, 2025
Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical TrialShan-Shan Guo, Xiao-Yun Li, Li-Ting Liu, et al.
Pageof 50